Molecular stratification and transcriptome-guided therapeutics in systemic lupus erythematosus with insufficient treatment response

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus

Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways

Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus

EULAR 2023 Recommendations for the Management of Systemic Lupus Erythematosus: One Step Forward

JAK Inhibition as a Potential Treatment Target in Systemic Lupus Erythematosus

Management of systemic lupus erythematosus: A new scenario

Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study

Understanding and managing cardiac involvement in systemic sclerosis

Outcome measures used in psoriatic arthritis registries and cohorts: A systematic literature review of 27 registries or 16,183 patients

Non-Invasive Assessment of Micro- and Macrovascular Function after Initiation of JAK Inhibitors in Patients with Rheumatoid Arthritis

Mediterranean diet and exercise are associated with better disease control in psoriatic arthritis

Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial

Effects of treatment with janus kinase inhibitors on coronary microvascular perfusion in patients with rheumatoid arthritis: an observational prospective cohort study